Trading status Status de
  • Prices realtime
    • Indizes
      • Germany 40
      • MID Germany 50
      • TEC Germany 30
      • USA 30
      • EUROPE 50
      • TEC USA 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 1796
  • 1797
  • 1798
  • …
  • ›
  • »

2026-08-17

First Gen plunges 19% after parent rejects KKR offer

2026-08-17

Ebang International GAAP EPS of -$0.46, revenue of $3.92M

2026-08-17

Research: UBS Cuts SAMSONITE TP to HKD20, Expects Revenue Weakness to Extend into 3Q26

2026-08-17

EQS-News: Pascal Wehrlein becomes Formula E World Champion with Porsche again

2026-08-17

Share buybacks in Ericsson during the period August 10 - August 14, 2026

2026-08-17

RXT Investors Have Opportunity to Lead Rackspace Technology, Inc. Securities Fraud Lawsuit with SBS Law

2026-08-17

Argenx Announces Positive Phase 3 ALKIVIA Results For VYVGART Hytrulo In Autoimmune Myositis

2026-08-17

Arc Minerals counts down to new drilling at Virgo copper project

2026-08-17

OceanaGold Announces Acquisition of Ausgold

2026-08-17

Did Perpetua Resources Corp. Insiders Breach their Fiduciary Duties to Shareholders?

2026-08-17

Aurum extends gold resource potential with 80g/t hit in West Africa

2026-08-17

AstraZeneca To Cease EVOLVE-Lung02 Phase III Trial Of Volrustomig + Chemotherapy In MNSCLC

  • «
  • ‹
  • …
  • 1796
  • 1797
  • 1798
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies